Open access · CC-BY
via OpenAlex
Rapamycin Is Neuroprotective in a Rat Chronic Hypertensive Glaucoma Model
Wenru Su, Zuohong Li, Yu Jia, Yehong Zhuo
PLoS ONE · 2014 · ▲ 90 citations
Altered intercellular communication
Rapamycin / mTOR inhibition
Cell culture / in vitro
Rat
In vitro
Abstract
Glaucoma is a leading cause of irreversible blindness. Injury of retinal ganglion cells (RGCs) accounts for visual impairment of glaucoma. Here, we report mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) protects RGCs from death in experimental glaucoma model and the underlying mechanisms. Our results showed that treatment with rapamycin dramatically promote RGCs survival in a rat chronic ocular hypertension model. This protective action appears to be attributable to inhibition of neurotoxic mediators release and/or direct suppression of RGC apoptosis. In support of this mechanism, in vitro, rapamycin significantly inhibits the production of NO, TNF-α in BV2 microglials by modulating NF-κB signaling. In experimental animals, treatment with rapamycin also dramatically inhibited the activation of microglials. In primary RGCs, rapamycin was capable of direct suppression the apoptosis of primary RGCs induced by glutamate. Mechanistically, rapamycin-mediated suppression of RGCs apoptosis is by sparing phosphorylation of Akt at a site critical for maintenance of its survival-promoting activity in cell and animal model. These results demonstrate that rapamycin is neuroprotective in experimental glaucoma, possibly via decreasing neurotoxic releasing and suppressing directly apoptosis of RGCs.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1371/journal.pone.0099719
- Canonical
- link ↗
- Fetched
- 2026-06-29 MST
Cite this
APA
Su, W., Li, Z., Jia, Y., & Zhuo, Y. (2014). Rapamycin Is Neuroprotective in a Rat Chronic Hypertensive Glaucoma Model. <em>PLoS ONE</em>. https://doi.org/10.1371/journal.pone.0099719
Vancouver
Su W, Li Z, Jia Y, Zhuo Y. Rapamycin Is Neuroprotective in a Rat Chronic Hypertensive Glaucoma Model. PLoS ONE. 2014. doi:10.1371/journal.pone.0099719.
BibTeX
@article{wenru2014Rapamy,
title = {Rapamycin Is Neuroprotective in a Rat Chronic Hypertensive Glaucoma Model},
author = {Wenru Su and Zuohong Li and Yu Jia and Yehong Zhuo},
journal = {PLoS ONE},
year = {2014},
doi = {10.1371/journal.pone.0099719},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cell Research 2022
Open access · OA
Discovery of small-molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and their preclinical neuroprotective activity
Neurobiology of aging 2026
Citation only
Exogenous mitochondrial transplantation attenuates oxidative stress-driven retinal degeneration in a sodium iodate - induced mouse model.
Haematologica 2011
Open access · OA
The role of sirtuin 2 activation by nicotinamide phosphoribosyltransferase in the aberrant proliferation and survival of myeloid leukemia cells
Antioxidants 2021
Open access · CC-BY
Bacillus amyloliquefaciens SC06 Induced AKT–FOXO Signaling Pathway-Mediated Autophagy to Alleviate Oxidative Stress in IPEC-J2 Cells
bioRxiv (Cold Spring Harbor Laboratory) 2024
Preprint · CC-BY
Oral supplementation with Nicotinamide Riboside treatment protects RGCs in DBA/2J mouse model
Cell Death and Disease 2019
Open access · CC-BY